Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Lunn and Stephen Keddie.
Michael Lunn
Connection Strength
2.315
Stephen Keddie
  1. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 03 03; 144(2):682-693.
    View in: PubMed
    Score: 0.932
  2. Laboratory biomarkers associated with COVID-19 severity and management. Clin Immunol. 2020 12; 221:108614.
    View in: PubMed
    Score: 0.909
  3. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 06 22; 144(5):e47.
    View in: PubMed
    Score: 0.238
  4. Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. EClinicalMedicine. 2021 Sep; 39:101070.
    View in: PubMed
    Score: 0.060
  5. Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study. Brain Commun. 2021; 3(3):fcab168.
    View in: PubMed
    Score: 0.060
  6. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Commun. 2021; 3(3):fcab099.
    View in: PubMed
    Score: 0.059
  7. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020 10 01; 143(10):3104-3120.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.